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CASE REPORT
Q fever is a zoonotic disease caused by the 
organism Coxiella burnetii, which has a world-
wide distribution.1–12 C. burnetii is notorious for
its ability to survive for an extended period out-
side of the reservoir and for its extreme infectious-
ness.10 Humans are typically infected through
inhaled infectious aerosols or drinking contami-
nated milk.1,10–12 The clinical presentations include
flu-like syndrome, prolonged fever, pneumonia,
hepatitis, pericarditis, myocarditis, endocarditis,
and meningoencephalitis.10 The existence of Q
fever in Taiwan was first documented in 1993.13
The majority of cases were reported from south-
ern Taiwan.6,14–16 The most common presenta-
tion is acute febrile illness of unknown origin,
with or without abnormal liver function.6,14,15
Jaundice is rare, but two cases with severe jaun-
dice mimicking acute cholangitis or acute viral
hepatitis have been described.6 We now report 
a case of fulminant acute Q fever presenting as
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We report a case of fulminant acute Q fever presenting as fever of unknown origin with rapidly progressive
hepatic failure in a patient with alcoholism. A 51-year-old electrician, who was a habitual drinker, pre-
sented with a 2-week history of intermittent high fever, acute hepatomegaly and rapidly progressive jaun-
dice after being accidentally exposed to dust from bird nests when he was repairing electrical equipment
and circuitry at an abandoned factory in Taipei County. Ascites and prolonged prothrombin time were
noted at admission. Transjugular liver biopsy and bone marrow biopsy found multiple small fibrinoid-
ring granulomas in liver parenchyma and bone marrow. Doxycycline therapy was empirically started. The
fever gradually subsided over a 2-week period, along with the recovery of liver function. The diagnosis of
acute Q fever was confirmed by high titers of antibodies against Coxiella burnetii (phase I IgM 1:160 and
IgG 1:2560, phase II IgM > 1:320 and IgG 1:5120) and a four-fold elevation of phase II IgG titer in the
paired serum. The experience of this case shows that the possibility of Q fever should not be overlooked in
patients who have an unexplained febrile illness and severe liver function impairment following exposure
to a contaminated environment in Taiwan. [J Formos Med Assoc 2008;107(11):896–901]
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fever of unknown origin with rapidly progressive
hepatic failure, which was successfully treated
with timely doxycycline therapy.
Case Report
A 51-year-old electrician was referred to our hos-
pital on May 14, 2005 with a 2-week history of
intermittent high fever, acute hepatomegaly and
rapidly progressive jaundice. He was a habitual
drinker for at least 15 years, and had consumed
about four bottles of Kaoliang Liquor per day in
recent years. There were no known medical dis-
eases, except that anti-HCV was known to be
positive 7 years ago. On April 28, 2005, he was
accidentally exposed to a large amount of dust
from bird nests when he repaired electrical equip-
ment and circuitry at an abandoned factory in
Taipei County. Three days later, high fever and tea-
colored urine developed. He took some antipy-
retics but the fever did not resolve. On May 10,
he was admitted to a community hospital where
physical examination revealed jaundice and a non-
tender liver enlarged to 2 cm below the costal
margin. Blood tests revealed a white cell count 
of 9.06 × 103/mm3, C-reactive protein (CRP) of
26.39 mg/dL, serum aspartate aminotransferase
(AST) of 264 IU/L, alanine aminotransferase (ALT)
of 106IU/L, total/direct bilirubin of 5.6/4.5mg/dL,
alkaline phosphatase (ALP) of 490 IU/L, and γ-
glutamyltransferase (GGT) of 1054 IU/L. Abdom-
inal ultrasound showed hepatosplenomegaly, mild
ascites, and bilateral pleural effusion, without an
obvious focal lesion or biliary tract dilatation.
Ceftriaxone (1 g every 12 hours) was given empir-
ically, but spiking fever persisted. In the following
days, the jaundice rapidly progressed (total/direct
bilirubin, 9.4/9.3 mg/dL), and the liver enlarged
to 6 cm below the costal margin. Blood culture was
negative. Disseminated tuberculosis was suspected.
However, antituberculous therapy was considered
too risky in the presence of rapidly progressive
hepatic failure. He was referred to our hospital.
On admission, his consciousness was clear,
with body temperature of 39°C, pulse rate of
100/min, respiration rate of 22/min, and blood
pressure of 114/70 mmHg. The sclera was icteric.
The neck was supple. There was neither lymph-
adenopathy nor oral thrush. Breath sounds were
decreased, with bilateral basal crackles. Heart
rhythm was regular without audible murmurs.
The abdomen was soft, without tenderness or re-
bounding pain. The liver was enlarged to 6 cm
below the right costal margin. There was an in-
crease in left upper quadrant dullness. There were
no other significant physical findings. Complete
blood count revealed a white blood cell count 
of 12.4 × 103/mm3 with neutrophils 73%, hemo-
globin of 12.4 g/dL, and platelet count of 202 ×
103/mm3. Serum biochemical study showed total/
direct bilirubin of 9.4/9.38 mg/dL, albumin of
2.53 g/dL, AST of 88 IU/L, ALT of 53 IU/L, ALP of
958 IU/L, GGT of 762 IU/L, and CRP of 17.28 mg/
dL. Prothrombin time was prolonged (16.1 sec-
onds; international normalized ratio [INR] was
1.3). Renal function tests were normal, with cre-
atinine of 0.8 mg/dL and blood urea nitrogen of
10.7 mg/dL. There was no pyuria. Chest X-ray
showed blunting of bilateral costophrenic angles,
but no pneumonia (Figure 1). Both abdominal so-
nography and abdominal computed tomography
Figure 1. Chest radiography on admission shows blunting
of bilateral costophrenic angles. There was no evidence of
pneumonia.
P.H. Lin, et al
898 J Formos Med Assoc | 2008 • Vol 107 • No 11
demonstrated hepatosplenomegaly, ascites, and bi-
lateral pleural effusion. Cefotaxime (1 g every 6
hours) and doxycycline (100 mg twice daily) were
started empirically on May 14, 2005. Leptospiro-
sis, Q fever, disseminated tuberculosis, and non-
Hodgkin’s lymphoma were considered as the
differential diagnoses. Nevertheless, needle live bi-
opsy could not be performed due to the presence of
both ascites and a prolonged prothrombin time.
Transjugular liver biopsy and bone marrow
biopsy were performed on May 19, 2005 after
prolonged prothrombin time was corrected by
fresh frozen plasma infusion. Multiple small 
fibrinoid-ring granulomas were found in liver
parenchyma and bone marrow (Figures 2A, B
and C), without acid-fast bacilli or periodic acid-
Schiff-positive fungi. Mallory bodies and focal
macrovesicular steatosis were also seen in liver
parenchyma, compatible with alcoholic liver 
disease. Masson’s trichrome stain showed fibrous
bands around regenerative liver parenchyma, in-
dicating progression to cirrhotic stage (Figure 2D).
Serologic tests for Leptospira, HAV, HBV, and HEV
were all non-reactive. Anti-HCV was positive but
blood HCV-RNA was undetectable. Results of an-
tinuclear antibody, anti-DNA (EIA), anti-ENA and
ANCA were all negative or within reference range.
HLA-B27 was positive. All blood cultures, bone
marrow cultures, Widal test, Weil-Felix test, cryp-
tococcal antigen, Toxoplasma IgM, and anti-HIV
turned out to be negative. Doxycycline therapy
was continued. Fever and jaundice gradually sub-
sided over a 2-week period, along with the nor-
malization of CRP levels (Figure 3). High titers
of IgM and IgG against C. burnetii in serum sam-
pled at admission were reported by the reference
laboratory of the Centers for Disease Control
(Taipei, Taiwan) (Table), with a four-fold elevation
A B
C D
Figure 2. Histopathology of liver and bone marrow. Hematoxylin and eosin staining shows: (A, B) multiple granuloma
disseminated in the liver parenchyma, as indicated by arrowheads; (C) fibrinoid ring granuloma in bone marrow. (D)
Masson’s trichrome staining shows fibrous bands (blue) around regenerative liver parenchyma (red, lower right), indicating
progression to cirrhotic stage. (Original magnification, 40×, 100×, 200×, and 100×, respectively).
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of phase II IgG titer in the paired serum.
Echocardiography found no evidence of infective
endocarditis. The eventual diagnosis was acute Q
fever with granulomatous hepatitis.
Because of the unusual severity of the disease
and a high initial titer of phase I IgG in this patient,
hydroxychloroquine (200 mg twice daily) was
added to the regimen. AST and ALT returned to
normal range on June 9, 2005. Albumin returned
to normal range on June 30, 2005. Bilirubin re-
turned to normal range on July 15, 2005 (Figure 3).
Prothrombin time remained slightly prolonged
(14.6 seconds; INR, 1.28) at the last test performed
on June 20, 2005. After a 6-week treatment, follow-
up phase I IgG titer remained at 1:2560+ (sam-
pled on July 15, 2005) (Table). The combination
therapy was thus continued for more than 18
months. He remains well and leads an active life.
Discussion
Q fever can present with extremely variable symp-
toms and signs.1–12 The proportion of people
Table. Results of Q fever serology by indirect immunofluorescence technique
Phase I antibody titers Phase II antibody titers
IgM IgG IgM IgG
2005/05/17 1:160+ 1:2560+ > 1:320+ 1:5120+
2005/05/31 1:160+ 1:2560+ > 1:320+ > 1:5120+
2005/07/15 1:640+ 1:2560+ 1:1280+ 1:20,480+
2005/12/20 1:40+ 1:1280+ 1:80+ 1:2560+
2007/06/09 Negative > 1:320+ 1:80+ > 1:320+
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Figure 3. Normalization of liver function after the start of doxycycline therapy on May 14, 2005. CRP = C-reactive protein;
AST = aspartate aminotransferase; ALT = alanine aminotransferase; PT = prothrombin time; INR = international normalized
ratio.
presenting with pneumonia and/or hepatitis varies
greatly from series to series and depends on the
geographic region.11 Compared with patients who
present with hepatitis, those who present with
pneumonia are older and more likely to be im-
munocompromised.3 But differences in reported
clinical presentations could also be partially ex-
plained by different case definitions and selection
biases in cases referred to specialists who publish
series.12 Hepatitis is a common presentation in
France,3 southern Spain,4 Israel,5 Taiwan6 and
southern California.7 Rapidly progressive hepatic
failure as seen in the present case, however, is un-
usual.6,14–16 The unusual severity of diseases in
this patient may be related to underlying alco-
holism and alcoholic liver disease, as well as a
large amount of organisms inhaled during the
exposure accident.
The diagnosis of Q fever is based on serology
using indirect immunofluorescence technique 
in most clinical scenarios.1 A four-fold increase
in phase II IgG is diagnostic for acute Q fever.10
Significant titers may take 3–4 weeks to appear,
so treatment should be started as soon as a clini-
cian suspects the disease to be present.12 The sen-
sitivity of serum polymerase chain reaction as an
early diagnostic tool remains unsatisfactory.17
Histologic findings of hepatic granuloma may be
nonspecific or may have a distinctive doughnut
appearance.1 In the present case, the probabilities
of an alternative diagnosis, including disseminated
tuberculosis and non-Hodgkin’s lymphoma which
require prompt specific therapy, mandated a liver
biopsy. Despite the presence of ascites and a pro-
longed prothrombin time, the procedure was safely
performed through a transjugular route and pro-
vided information that was highly valuable for
clinical management before the diagnosis was
eventually confirmed by serology.
Doxycycline, 100 mg twice daily for 14 days is
recommended for acute illness.10,12 For chronic
Q fever, the treatment should be continued until
phase I IgG titer is less than 1:200.10 Chloroquine
increases the efficacy of doxycycline,18 and the
combination of doxycycline and hydroxychloro-
quine has been shown to shorten the treatment
duration for Q fever endocarditis.19 Because of the
unusual severity of disease and a high initial titer
of phase I IgG in this patient, we added hydroxy-
chloroquine to the regimen and extended the
treatment duration to minimize the risk of devel-
opment of chronic Q fever.
The experience of the present case shows that
the possibility of Q fever should not be overlooked
in patients who have an unexplained febrile ill-
ness and severe liver function impairment follow-
ing exposure to a contaminated environment in
Taiwan. Early diagnosis and timely appropriate
therapy can be life-saving.
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